Nash Pharmaceuticals Announces Positive Pre-Clinical Results For Its Lead Compound NP-135 in Chronic Kidney Disease
November 19, 2018 07:00 ET
|
Breathtec Biomedical Inc.
Planning Phase II Trial VANCOUVER, B.C., Nov. 19, 2018 (GLOBE NEWSWIRE) -- Nash Pharmaceuticals Inc., a wholly owned subsidiary of Breathtec Biomedical Inc. (CSE: BTH) (CNSX: BTH) (FRANKFURT: BTI)...
Nash Pharmaceuticals Announces Positive Pre-Clinical Results For Its Lead Compound NP-178 in Inflammatory Bowel Disease
November 13, 2018 07:00 ET
|
Breathtec Biomedical Inc.; Nash Pharmaceuticals Inc.
Planning Phase II Trial VANCOUVER, British Columbia, Nov. 13, 2018 (GLOBE NEWSWIRE) -- Nash Pharmaceuticals Inc., a wholly owned subsidiary of Breathtec Biomedical Inc. (CSE: BTH) (CNSX: BTH)...
DiaMedica Therapeutics Has Applied to List its Common Shares on Nasdaq, Announces Share Consolidation
November 12, 2018 16:45 ET
|
DiaMedica Therapeutics Inc.
MINNEAPOLIS, Nov. 12, 2018 (GLOBE NEWSWIRE) -- DiaMedica Therapeutics Inc. (TSX Venture:DMA) (OTCQB:DMCAF), a clinical stage biopharmaceutical company, announced today that it has applied to list...
DiaMedica Therapeutics Announces Results From Annual General and Special Meeting of Shareholders
November 06, 2018 17:00 ET
|
DiaMedica Therapeutics Inc.
MINNEAPOLIS, Nov. 06, 2018 (GLOBE NEWSWIRE) -- DiaMedica Therapeutics Inc. (TSX-V:DMA) (OTCQB:DMCAF), a clinical stage biopharmaceutical company, today announced the voting results from its Annual...
American Kidney Fund Joins Kidney Community in Call for Public-Private Partnerships to Spark Innovation
September 28, 2018 09:00 ET
|
American Kidney Fund
ROCKVILLE, Md., Sept. 28, 2018 (GLOBE NEWSWIRE) -- The American Kidney Fund (AKF), the nation’s largest independent nonprofit fighting kidney disease, today joins with the Congressional Kidney...
DiaMedica Therapeutics Announces the Appointment of Dr. Harry Alcorn Jr. as Chief Medical Officer
September 05, 2018 08:00 ET
|
DiaMedica Therapeutics Inc.
MINNEAPOLIS, Sept. 05, 2018 (GLOBE NEWSWIRE) -- DiaMedica Therapeutics Inc. (the “Company” and “DiaMedica”) (TSX-V:DMA) (OTCQB:DMCAF) announces the recent appointment of Harry Alcorn Jr. Pharm.D. as...
Breathtec to Open New Drug Development Division, Signs LOI to acquire 100% of Clinical Stage Nash Pharmaceuticals Inc.
August 02, 2018 07:00 ET
|
Breathtec Biomedical Inc.
VANCOUVER, British Columbia, Aug. 02, 2018 (GLOBE NEWSWIRE) -- Breathtec Biomedical Inc. (CSE: BTH) (CNSX: BTH) (FRANKFURT: BTI) (OTCQB: BTHCF) (the “Company”) is pleased to announce that it will be...
Stanford Nephrology Fellow Katherine M. Wang Named American Kidney Fund Clinical Scientist in Nephrology
July 10, 2018 15:47 ET
|
American Kidney Fund
ROCKVILLE, Md., July 10, 2018 (GLOBE NEWSWIRE) -- Katherine M. Wang, M.D., a second-year nephrology fellow at Stanford University, has been named the American Kidney Fund (AKF) Clinical Scientist...
American Kidney Fund Launches Comprehensive New Kidney Disease Education Portal
May 16, 2018 11:30 ET
|
American Kidney Fund
ROCKVILLE, Md., May 16, 2018 (GLOBE NEWSWIRE) -- The American Kidney Fund (AFK) today unveiled CKD Central, a new free online education portal offering comprehensive information and resources on...
DiaMedica Announces Positive Results From FDA Meeting on Planned Clinical Trial in Patients with Chronic Kidney Disease
May 03, 2018 08:30 ET
|
DiaMedica Therapeutics Inc.
DiaMedica has received final minutes from Type B meeting with the US FDADiaMedica preparing to submit an IND to initiate DM199 clinical study in patients with chronic kidney disease in the US ...